Results 181 to 190 of about 69,858 (347)

Safety and Efficacy Findings From a Phase Ib/II Study of ASP‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

open access: yesHead &Neck, Volume 48, Issue 1, Page 160-174, January 2026.
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti   +17 more
wiley   +1 more source

Prämedikationsqualität und Patientenzufriedenheit nach Prämedikation mit Midazolam, Clonidin oder Placebo: Randomisierte Doppelblindstudie mit altersangepasster Dosierung [PDF]

open access: yes, 2018
Zusammenfassung: Hintergrund: Die Prämedikation hat u.a. zum Ziel, Angstgefühle und innere Unruhe vor einem chirurgischen Eingriff zu lindern und gleichzeitig möglichst wenig unerwünschte Wirkungen zu verursachen. Es gibt bisher keine Untersuchungen, die
Ivleva-Sauerborn, A.   +3 more
core  

Linking Health Financing to Oral Health Coverage and Disease Burden in SEARO Countries: A Cross‐Sectional Analysis of Country Level Data

open access: yesThe International Journal of Health Planning and Management, Volume 41, Issue 1, Page 47-58, January 2026.
ABSTRACT Introduction The Southeast Asian region of World Health Organization (SEARO) comprising 11 countries, that is Bangladesh, Bhutan, Democratic People's Republic of Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand, and Timor‐Leste is home to a quarter of the world's population where severe oral health disparities persist ...
Shashidhar Acharya   +3 more
wiley   +1 more source

Norepinephrine Involvment in Penile Detumescence [PDF]

open access: yes, 1990
Diederichs, W.   +3 more
core   +1 more source

Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 215-222, January 2026.
Abstract Objective To compare overall survival (OS) in patients with high‐grade serous ovarian cancer (HGSOC) treated with intraperitoneal (IP) chemotherapy versus intravenous (IV) chemotherapy. Methods A retrospective study of Stage III HGSOC with optimal primary cytoreduction during 2007–2019, followed by adjuvant IP or IV chemotherapy.
Joshua S Cheruvathur   +7 more
wiley   +1 more source

Clinical and Biochemical Factors Associated With Infliximab Pharmacokinetics in Adult Patients With Inflammatory Bowel Disease

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Many patients with inflammatory bowel disease (IBD) do not adequately respond to infliximab, potentially due to individual differences in pharmacokinetics (PK). This study aimed to identify clinical and biochemical variables associated with infliximab PK.
Ilse A. Pool   +6 more
wiley   +1 more source

UK Paramedic Rapid Sequence Intubation...Is it viable? [PDF]

open access: yes
This report details the indications and drug requirements of Rapid Sequence Intubation (RSI), then proceeds to discuss the literature and evidence surrounding RSI with a view to answering the question: Can UK Paramedics perform RSI? And more importantly,
Gubbins, Karen
core  

Risk Factors of Hematological Toxicity of Mesothelioma Treatment—A Territory‐Wide Retrospective Study

open access: yesThoracic Cancer, Volume 17, Issue 2, January 2026.
We examined the prevalence and risk factors of hematological toxicities associated with mesothelioma treatment in this territory wide retrospective study in Hong Kong. We demonstrated that hematological toxicities were common in the treatment course of mesothelioma.
Wang Chun Kwok   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy